CAMG Solamere Management’s Pfizer PFE Stock Holding History

CAMG Solamere Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$872K	Hold	20,273	–	–	0.72%	52
2021 Q2	$794K	Sell	20,273 -27,993	-58%	-$1.09M	0.69%	54
2021 Q1	$1.75M	Sell	48,266 -1,729	-3%	-$61.4K	1.51%	23
2020 Q4	$1.84M	Sell	49,995 -38,136	-43%	-$1.4M	1.55%	18
2020 Q3	$3.07M	Buy	88,131 +197	+0.2%	+$6.91K	1.71%	12
2020 Q2	$2.73M	Sell	87,934 -2,244	-2%	-$76.2K	1.5%	13
2020 Q1	$2.79M	Buy	90,178 +52,684	+141%	+$1.8M	1.47%	23
2019 Q4	$1.4M	Sell	37,494 -627	-2%	-$22.3K	0.64%	48
2019 Q3	$1.3M	Hold	38,121	–	–	0.65%	48
2019 Q2	$1.57M	Hold	38,121	–	–	0.72%	45
2019 Q1	$1.54M	Sell	38,121 -427	-1%	-$17.1K	0.76%	44
2018 Q4	$1.6M	Buy	38,548 +206	+0.5%	+$8.55K	0.89%	43
2018 Q3	$1.6M	Buy	38,342 +341	+0.9%	+$13.1K	0.82%	47
2018 Q2	$1.31M	Buy	38,001 +324	+0.9%	+$11.1K	0.64%	53
2018 Q1	$1.27M	Buy	37,677 +178	+0.5%	+$6.12K	0.58%	56
2017 Q4	$1.29M	Buy	37,499 +300	+0.8%	+$10.2K	0.57%	58
2017 Q3	$1.26M	Buy	37,199 +1,803	+5%	+$57.9K	0.63%	57
2017 Q2	$1.13M	Buy	35,396 +772	+2%	+$24.3K	0.64%	54
2017 Q1	$1.12M	Buy	+34,624	New	+$1.09M	0.66%	53

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CAMG Solamere Management's PFE Position: Q3 2021 in Review

CAMG Solamere Management held its Pfizer (PFE) position steady in Q3 2021 at 20,273 shares worth $872K. The position accounts for 0.72% of the portfolio, ranked #52.

CAMG Solamere Management first reported a position in PFE in Q1 2017 and has held it in 19 quarters since. The position peaked at $3.07M in Q3 2020. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

CAMG Solamere Management held 20,273 shares of Pfizer worth $872K as of Q3 2021.
CAMG Solamere Management left its Pfizer share count unchanged in Q3 2021.
Pfizer made up 0.72% of CAMG Solamere Management's portfolio in Q3 2021, its #52 holding.
CAMG Solamere Management first reported a position in Pfizer in Q1 2017 and has held it in 19 quarters since.
CAMG Solamere Management's Pfizer position peaked at $3.07M in Q3 2020.
2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on CAMG Solamere Management's 13F filing for Q3 2021, filed 12 Nov 2021.